Blue nevus is a benign melanocytic lesion whose most frequent variants are dendritic (common) blue nevus and cellular blue nevus. Atypical cellular blue nevus presents an intermediate histopathology ...

In a recent study, researchers aimed to evaluate whether and how PFAS affect the second arm of the immune system, the so-called cellular immune response. This is especially important in the case ...

The team has identified a small molecule that can selectively block cell death. Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced ...

As an extension of the central nervous system, it offers researchers a unique, noninvasive means to visualize neurons at the cellular level. "These retinal cells serve as surrogates for studying ...

In research published in New Phytologist, investigators reveal that tomato ripening is regulated by the same mechanism that contributes to humans' and animals' life- and health spans. The ...

Hirayama and Suzuki [13] examined the histological findings of 450 cases of nevus of Ota and classified the condition according to the distribution of the dermal melanocytes as follows ...

An often-ignored type of cell in the brain plays a dynamic and surprisingly complex role in our ability to process information, according to new research. An often-ignored type of cell in the ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the company is a “little late to join the party.” But just because AZ has ...